Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-19

Clinical Trial Update: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues [Phase 3]

View source ↗

Summary

Phase 3 trial assessing prostaglandin analogue drops for treating soft tissue expansion in inactive thyroid eye disease (thyroid-associated ophthalmopathy) has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rabin Medical Center | Conditions: Thyroid Associated Ophthalmopathies | Phase 3 | Status: COMPLETED